𝗩𝗮𝘅𝘅𝗶𝗻𝗼𝘃𝗮 𝗮𝗰𝗾𝘂𝗶𝗿𝗲𝘀 𝗔𝘃𝗶𝘀𝗵𝗶𝗲𝗹𝗱® poultry vaccine 𝗿𝗮𝗻𝗴𝗲 𝗮𝗻𝗱 𝗥&𝗗 𝘁𝗲𝗮𝗺 in Zagreb, Croatia 

This acquisition marks a significant milestone in our growth, enabling us to:

• Offer a complete portfolio of live vaccines against Infectious Bronchitis (IB), Gumboro Disease (IBD) and Newcastle Disease (ND)
• Have direct access to the European poultry vaccines market and strengthen our presence in the international markets
• Continue the development of the corresponding R&D pipeline by the Zagreb R&D team

Victor van Solinge, Chief Executive Officer of Vaxxinova, remarked “The addition of the Avishield® portfolio significantly strengthens our position in the poultry vaccine market and complements our existing VAXXON® range. We are excited to welcome the R&D team in Zagreb, whose expertise will be instrumental to further extend our portfolio. This acquisition underlines our long-term commitment to the poultry industry.”

Dechra and Vaxxinova agreed on a smooth transition period, securing business continuity.

We’re excited about the opportunities this brings to our partners, customers, and the broader animal health community.